New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
10:07 EDTREPH, HOLI, BMRN, AEO, RSPP, CSTM, ATW, ALE, SNSS, NMM, CAB, ATHL, ARIAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ARIAD (ARIA) coverage transitioned with a Neutral at UBS... Allete (ALE) initiated with a Neutral at JPMorgan... American Eagle (AEO) initiated with a Fair Value at CRT Capital... Athlon Energy (ATHL) initiated with a Buy at Mizuho... Atwood Oceanics (ATW) initiated with a Hold at Deutsche Bank... BioMarin (BMRN) coverage transitioned with a Buy at UBS... Cabela's (CAB) initiated with a Neutral at Goldman... Constellium (CSTM) initiated with a Buy at Sterne Agee... Hollysys Automation (HOLI) initiated with a Buy at Goldman... Navios Maritime Partners (NMM) initiated with a Buy at Jefferies... RSP Permian (RSPP) initiated with a Buy at Mizuho... Recro Pharma (REPH) initiated with a Buy at Aegis... Sunesis (SNSS) initiated with a Buy at UBS.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 7, 2015
05:27 EDTCSTMConstellium partners with STELIA Aerospace, CT INGENIERIE to explore 3D printing
Constellium announced that it has formed a partnership with STELIA Aerospace and CT INGENIERIE to engage in a research and development project called FAST, focused on topological optimization of aero structures and additive manufacturing, also known as 3D printing.
July 6, 2015
15:36 EDTATWAtwood subsidiary extends contract for Atwood Beacon
Subscribe for More Information
July 2, 2015
13:59 EDTBMRNNHS to wait on NICE to make call on PTC Therapeutics, BioMarin drugs
NHS England has set out its planned investment decisions for certain specialized services as part of its annual commissioning round. NHS England has agreed with the recommendations from CPAG that final funding decisions on the following two treatments should be made after NICE has concluded its Highly Specialized Technology Appraisal process: BioMarin Pharmaceutical's (BMRN) Vimizim for Morquio A Syndrome and PTC Therapeutics' (PTCT) Translarna for Duchenne muscular dystrophy. The decisions on those two drugs came among 39 proposed new investments that the group said were "carefully considered against the principles NHS England follows when making investment decisions." Reference Link
08:35 EDTALEALLETE Clean Energy acquires Pennsylvania Wind Facility from AES Corp.
Subscribe for More Information
July 1, 2015
09:24 EDTREPHRecro Pharma raises $16M in a private placement
Subscribe for More Information
June 30, 2015
09:57 EDTRSPPRSP Permian management to meet with Jefferies
Subscribe for More Information
09:27 EDTNMMNavios Maritime Partners announces long-term charter
Subscribe for More Information
June 29, 2015
12:53 EDTBMRNSarepta NDA submission for eteplirsen done ahead of schedule, says Piper Jaffray
Piper Jaffray noted that Sarepta (SRPT) completed its rolling NDA submission for eteplirsen ahead of schedule and the firm believes that concurrent advisory committee meetings for its DMD drug and BioMarin's (BMRN) drisapersen could take place this fall. The firm has a Neutral rating and $20 price target on Sarepta and Overweight rating and $147 target on BioMarin.
08:36 EDTBMRNBioMarin announces FDA acceptance of drisapersen NDA
Subscribe for More Information
June 25, 2015
16:03 EDTBMRNBioMarin announces EMA validates MAA for drisapersen for treatment of DMD
Subscribe for More Information
10:00 EDTALEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:03 EDTHOLIHollysys Automation awarded SCADA contract for $21.26M
Subscribe for More Information
06:31 EDTALEAllete downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Allete to Underweight saying idlings of US Steel and potentially other mines will likely weigh on near-term earnings. The firm believes the mining risk is significant and not priced into consensus estimates. It cut its price target for shares to $47 from $53.
June 24, 2015
09:11 EDTAEOAmerican Eagle says environment continues to be highly promotional
Says "pleased" with 1H15 results. Says has seen "good" sequential improvement starting from 2H14 through 1Q15 and 2Q15. Says environment continues to be highly promotional, but seeing strength across all categories and regions. Says leveraging mall traffic, says AUR continues to grow, as well as unit volume. Sees room for improved merchandise margins in 2H. Sees continued EPS growth in 2H. Says "very" optimistic going into 2H. Comments made at the Oppenheimer Annual Consumer Conference.
09:04 EDTAEOAmerican Eagle repeats Q2 EPS view 11c-14c, consensus 14c
Subscribe for More Information
05:15 EDTCSTMConstellium, Linde announce joint development agreement
Constellium N.V. (CSTM) and Linde Gases, a division of The Linde Group (LNAGF), announced that they have signed a joint development agreement to use Linde's oxy-fuel technology in Constellium's recycling and melting furnaces, with a goal of cutting energy consumption by half while increasing melting rates by 20 percent. This announcement follows a long-term partnership with Linde in the area of energy-efficient re-melting technologies. The joint development agreement will build on the recent successful implementation of Linde's technology in Constellium's finishing and recycling aluminium facility of Neuf-Brisach, France, where two of the four rotary tilting furnaces have been converted to low-temperature oxy-fuel combustion technology. Following this implementation, Constellium was able to achieve greater productivity and to accelerate progress on its sustainability roadmap. The conversion of the remaining furnaces at the France plant is scheduled to be completed by the end of 2016.
June 23, 2015
07:49 EDTCSTMConstellium shares have 'meaningful' upside, says JPMorgan
Subscribe for More Information
07:49 EDTBMRNPTC Therapeutics risk lowered by symposium, says Oppenheimer
Subscribe for More Information
07:25 EDTBMRNPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:15 EDTAEOOppenheimer to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use